DP

Diadema Partners Portfolio holdings

AUM $161M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$161M
AUM Growth
+$35.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
94
New
Increased
Reduced
Closed

Top Buys

1
+$16M
2
+$14.5M
3
+$7.7M
4
TGTX icon
TG Therapeutics
TGTX
+$5.89M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.45M

Top Sells

1
+$12.7M
2
+$3.54M
3
+$3.5M
4
ARGX icon
argenx
ARGX
+$3.48M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$2.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
51
AnaptysBio
ANAB
$969M
– –
0
ASND icon
52
Ascendis Pharma
ASND
$12.7B
– –
-8,321
BBIO icon
53
BridgeBio Pharma
BBIO
$10.5B
– –
0
BHVN icon
54
Biohaven
BHVN
$1.69B
– –
0
BMEA icon
55
Biomea Fusion
BMEA
$107M
– –
0
CADL icon
56
Candel Therapeutics
CADL
$293M
– –
-25,045
CAPR icon
57
Capricor Therapeutics
CAPR
$286M
– –
0
CMPX icon
58
Compass Therapeutics
CMPX
$731M
– –
0
CNTA
59
Centessa Pharmaceuticals
CNTA
$3.09B
– –
-164,048
CORT icon
60
Corcept Therapeutics
CORT
$8.29B
– –
0
CRDF icon
61
Cardiff Oncology
CRDF
$146M
– –
0
CRSP icon
62
CRISPR Therapeutics
CRSP
$6.29B
– –
0
CYTK icon
63
Cytokinetics
CYTK
$6.99B
– –
-20,000
EOLS icon
64
Evolus
EOLS
$414M
– –
0
EWTX icon
65
Edgewise Therapeutics
EWTX
$1.59B
– –
0
FOLD icon
66
Amicus Therapeutics
FOLD
$2.48B
– –
0
GOSS icon
67
Gossamer Bio
GOSS
$501M
– –
-269,589
IMUX icon
68
Immunic
IMUX
$79M
– –
0
KALV icon
69
KalVista Pharmaceuticals
KALV
$561M
– –
-135,509
KROS icon
70
Keros Therapeutics
KROS
$421M
– –
0
MLTX icon
71
MoonLake Immunotherapeutics
MLTX
$579M
– –
0
MNKD icon
72
MannKind Corp
MNKD
$1.68B
– –
0
MREO
73
Mereo BioPharma
MREO
$326M
– –
-492,215
MRNA icon
74
Moderna
MRNA
$10.2B
– –
0
NKTR icon
75
Nektar Therapeutics
NKTR
$1.1B
– –
0
1 2
3
4